BLUTENTNAHMESPRITZE MIT HÄMOLYSESCHUTZ
European patent · EP4225402 · In force
Register entry
- Publication number
- EP4225402
- Application number
- EP21880815
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 8, 2021
- Published
- Aug 16, 2023
- Granted
- Jan 28, 2026
- Protection ends at the latest
- Oct 7, 2041
- Next annual fee due
- Oct 31, 2026
- IPC classes
- A61M 5/168 (2006.01)A61M 5/14 (2006.01)A61M 5/178 (2006.01)A61M 25/06 (2006.01)A61M 39/00 (2006.01)A61M 39/10 (2006.01)A61B 5/15 (2006.01)A61B 5/153 (2006.01)
- Priority
- US 202063090602 P 12.10.2020
- PCT application
- PCT/US2021/054078 08.10.2021
- PCT publication
- WO2022/081420 21.04.2022
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 28, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 28.01.2026
Parties
Inventor
MA, Yiping
Layton, Utah 84040, US
BURKHOLZ, Jonathan, Karl
Salt Lake City, Utah 84108, US
CICILIANO, Jordan
Durham, North Carolina 27707, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.